Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001104659-25-064754·MILLENNIUM MANAGEMENT LLC
Schedule 13G ownership disclosure
Vanda Pharmaceuticals Inc
Common Stock, par value $0.001 per share · CUSIP: 921659108
Event date: 2025-06-27
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Millennium Management LLC
Shares: 3,120,339.00 · Class: 5.3%
- Millennium Group Management LLC
Shares: 3,120,339.00 · Class: 5.3%
- Israel A. Englander
Shares: 3,120,339.00 · Class: 5.3%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-064754
- Form type
- SCHEDULE 13G
- Filer
- MILLENNIUM MANAGEMENT LLC
- CIK
- CIK 1273087
- Filed
- Jul 01, 2025
- Reporting period
- Jun 27, 2025
- Description
- Schedule 13G beneficial ownership